Search - tctmd.com

Displaying 421 - 440 of 1423

Sort: Relevancy | Date

Presentation TCT 2017

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: STS/AATS

Presenter: Wayne B. Batchelor, George A. Mensah, Vinod H. Thourani

October 30, 2017

Presentation TCT 2017

Why Are Hypertension and Coronary Artery Disease So Connected?

Presenter: Mark C. Bates, Bernard J. Gersh, Suzanne Oparil

October 30, 2017

Presentation TCT 2017

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: AHA

Presenter: Wayne B. Batchelor, George A. Mensah, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Counterpoint Access to Modern Valve Therapies for Underserved Populations Trumps Arbitrary Guidelines Favoring High-Volume Urban Centers!

Presenter: Uzoma Ibebuogu

October 30, 2017

Presentation TCT 2017

Alternatives to Traditional P-value Testing: Bayesian Designs

Presenter: Eugene H. Blackstone, Stuart J. Pocock, Roseann M White

October 30, 2017

Presentation TCT 2017

Point A Tiered Centers of Excellence Approach Makes Sense!

Presenter: Patrick T. O'Gara

October 30, 2017

Presentation TCT 2017

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: ACC

Presenter: Wayne B. Batchelor, George A. Mensah, Pamela S. Douglas

October 30, 2017

Presentation TCT 2017

Renal Artery Atherosclerosis and Secondary Hypertension: Frequency, Diagnosis, and Treatment

Presenter: Mark C. Bates, Bernard J. Gersh, Michael R. Jaff

October 30, 2017

Presentation TCT 2017

Beyond Time-to-First Event: Counting Multiple Events, Hierarchical Measures, and Weighted Composites

Presenter: Eugene H. Blackstone, Stuart J. Pocock, Jan G. P. Tijssen

October 30, 2017

Presentation TCT 2017

FDA Perspectives: Diversity in Clinical Trials and its Impact of Device Evaluation

Presenter: Wayne B. Batchelor, George A. Mensah, Christopher J Popma

October 30, 2017

Presentation TCT 2017

Counterpoint In the Modern Era, Crowd Wisdom, Cumulative Experience and New Technology Trumps Case Volume!

Presenter: Martin B. Leon

October 30, 2017

Presentation TCT 2017

Uncontrolled Hypertension Management Issues: Adherence, Testing, and Difficult Patient Scenarios

Presenter: Sidney C. Smith, Michael A. Weber

October 30, 2017

Presentation TCT 2017

Proper and Improper Interpretations of the P-value

Presenter: Eugene H. Blackstone, Stuart J. Pocock

October 30, 2017

Presentation TCT 2017

Point - Clearly, The More You Do, The Better You Are!

Presenter: John D. Carroll

October 30, 2017

Presentation TCT 2017

What is the Optimal Therapy for Hypertension?

Presenter: Sidney C. Smith, Michael A. Weber

October 30, 2017

Presentation TCT 2017

Featured Lecture: The Vancouver Multidisciplinary, Multimodality, but Minimalist Clinical Pathway Facilitates Safe Next Day Discharge Home at Low, Medium, and High Volume Transcatheter Aortic Valve Replacement Centres: the 3M TAVR Study

Presenter: Robert O. Bonow, Michael J. Mack, David A. Wood

October 30, 2017

Presentation TCT 2017

Office, Home, or Ambulatory Blood Pressure: How to Measure Blood Pressure in Practice and Clinical Trials

Presenter: Sidney C. Smith, Michael A. Weber, C. Venkata S. Ram

October 30, 2017

Presentation TCT 2017

Strengths and Limitations of Composite Endpoints (eg, EXCEL, PLATO, and Others)

Presenter: Roxana Mehran, Robert W. Yeh, Stuart J. Pocock

October 30, 2017

Presentation TCT 2017

How to Calculate Stroke and Bleeding Risk in Clinical Practice

Presenter: Christopher B. Granger, Horst Sievert, Ted Feldman

October 30, 2017

Presentation TCT 2017

PROPHET II Trial Summary and Clinical Implications

Presenter: Prashant Kaul, Jennifer A. Tremmel, Samir B. Pancholy

October 30, 2017

Advertisement

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: STS/AATS

Why Are Hypertension and Coronary Artery Disease So Connected?

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: AHA

Counterpoint Access to Modern Valve Therapies for Underserved Populations Trumps Arbitrary Guidelines Favoring High-Volume Urban Centers!

Alternatives to Traditional P-value Testing: Bayesian Designs

Point A Tiered Centers of Excellence Approach Makes Sense!

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: ACC

Renal Artery Atherosclerosis and Secondary Hypertension: Frequency, Diagnosis, and Treatment

Beyond Time-to-First Event: Counting Multiple Events, Hierarchical Measures, and Weighted Composites

FDA Perspectives: Diversity in Clinical Trials and its Impact of Device Evaluation

Counterpoint In the Modern Era, Crowd Wisdom, Cumulative Experience and New Technology Trumps Case Volume!

Uncontrolled Hypertension Management Issues: Adherence, Testing, and Difficult Patient Scenarios

Proper and Improper Interpretations of the P-value

Point - Clearly, The More You Do, The Better You Are!

What is the Optimal Therapy for Hypertension?

Featured Lecture: The Vancouver Multidisciplinary, Multimodality, but Minimalist Clinical Pathway Facilitates Safe Next Day Discharge Home at Low, Medium, and High Volume Transcatheter Aortic Valve Replacement Centres: the 3M TAVR Study

Office, Home, or Ambulatory Blood Pressure: How to Measure Blood Pressure in Practice and Clinical Trials

Strengths and Limitations of Composite Endpoints (eg, EXCEL, PLATO, and Others)

How to Calculate Stroke and Bleeding Risk in Clinical Practice

PROPHET II Trial Summary and Clinical Implications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content